Product Browser

Last updated: 2016/10/16

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

FCRLM1 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00084824-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-FCRLM1 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 41.47
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-FCRLM1 antibody (H00084824-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00084824-T01
    FCRLA transfected lysate.
    Western Blot
    QC Testing of H00084824-T01
    Lane 1: FCRLA transfected lysate ( 41.47 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Gene Name:
  • Gene Alias:
  • Gene Description:
  • Fc receptor-like A
  • Gene Summary:
  • Receptors for the Fc fragment of IgG, or FCGRs (see MIM 146790), are cell surface glycoproteins of the Ig superfamily (IgSF). These receptors mediate phagocytosis of IgG-coated pathogens and promote activation of effector cells, leading to inflammatory responses and antibody-mediated cellular cytotoxicity. All FCGR genes map to human chromosome 1. Additional genes in this region, including FREB, encode FCGR homologs that are selectively expressed in B cells and may be implicated in B-cell development and lymphomagenesis.[supplied by OMIM
  • Other Designations:
  • Fc receptor homolog expressed in B cells (FREB),Fc receptor related protein X,Fc receptor-like and mucin-like 1,OTTHUMP00000032485
  • RSS
  • YouTube
  • Linkedin
  • Facebook